Knight Therapeutics Inks License Agreement With Amneal Pharma For IPX203

RTTNews | 574 days ago
Knight Therapeutics Inks License Agreement With Amneal Pharma For IPX203

(RTTNews) - Specialty pharmaceutical company Knight Therapeutics Inc. (GUD.TO) announced Thursday it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. (AMRX), granting Knight the exclusive rights to seek regulatory approval and commercialize IPX203 in Canada and Latin America.

IPX203 is a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules designed for the treatment of Parkinson's disease. Financial terms of the agreement were not disclosed.

IPX203 contains immediate-release (IR) granules and extended-release (ER) coated beads. The IR granules consist of CD and LD, with a disintegrant polymer to allow for rapid dissolution.

IPX203 was studied in the RISE-PD clinical study which was a 20-week, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial with 630 patients. The RISE-PD study met its primary and secondary endpoints.

read more
Swiss Market Ends Weak

Swiss Market Ends Weak

The Switzerland market ended modestly lower on Thursday after languishing in negative territory right through the day's trading session, as the mood remained cautious with investors looking ahead to speeches from central bank chiefs at Federal Reserve's Jackson Hole Symposium.
RTTNews | 4h 22min ago
European Stocks Close On Mixed Note Again

European Stocks Close On Mixed Note Again

European stocks turned in another mixed performance as investors stayed a bit cautious on Thursday, looking ahead to Federal Reserve's symposium at Jackson Hole, Wyoming, and largely shrugging off trade concerns. Investors also digested the latest batch of regional economic data, including flash estimates of manufacturing and services sector activity in the major economies.
RTTNews | 4h 38min ago
U.S. Leading Economic Index Edges Down In Line With Estimates In July

U.S. Leading Economic Index Edges Down In Line With Estimates In July

A reading on leading U.S. economic indicators edged slightly lower in the month of July, according to a report released by the Conference Board on Thursday. The Conference Board said leading economic index slipped by 0.1 percent in July after falling by 0.3 percent in June. The modest decrease matched economist estimates.
RTTNews | 7h 21min ago
U.S. Existing Home Sales Unexpectedly Rebound In July

U.S. Existing Home Sales Unexpectedly Rebound In July

The National Association of Realtors released a report on Thursday showing an unexpected rebound by existing home sales in the U.S. in the month of July. The report said existing home sales jumped by 2.0 percent to an annual rate of 4.01 million in July after tumbling by 2.7 percent to an annual rate of 3.93 million in June.
RTTNews | 7h 32min ago